- Feb 24, 2001
- 18,307
- 4,241
- 113
- School/Org
- University of Michigan Medical School
- City
- Lake Oswego
- State
- OR
Dry Eye Disease is a highly prevalent condition that can have a major impact on cataract patients, both pre- and post-operatively.
For optimal surgical outcomes, it is critically important that the condition is addressed properly before a procedure takes place. As an OD co-managing these cases, it is up to you to make sure this happens.
In this exciting case-based webinar, Mile Brujic, OD, FAAO and Ranjan Malhotra, MD, FACS share clinical pearls with you and discuss:
* How to identify and work-up dry eye patients pre-operatively, including the latest diagnostic tests at your disposal
* What steps you can take as the co-managing OD to optimize the ocular surface preoperatively
* How ODs and OMDs can work collaboratively to ensure optimal patient outcomes
A Q&A with Drs. Brujic and Malhotra follows the talk
About the Speakers
Mile Brujic, OD, FAAO is a 2002 graduate of the New England College of Optometry. He is a partner of Premier Vision Group, a successful four location optometric practice in Northwest Ohio.
He practices full scope optometry with an emphasis on ocular disease management of the anterior segment and specialty contact lenses. He is active at all levels of organized optometry.
Dr. Brujic is on the editorial board for a number of optometric publications. He has published over 450 articles and has given over 2,000 lectures, both nationally and internationally on contemporary topics in eye care.
Ranjan Malhotra, MD, FACS, is a board-certified, fellowship-trained Ophthalmologist at Ophthalmology Associates, serving patients in the St. Louis area.
He attended the University of Missouri-Kansas City accelerated 6-year Bachelor's/Medical Degree program where he graduated with honors in 1995.
He completed his internship at St. John's Mercy in St. Louis, followed by a move to Dallas, TX to complete his residency in Ophthalmology at the University of Texas - Southwestern Medical Center.
He completed his fellowship in Cornea/External Disease and Refractive Surgery at the Dean McGee Eye Institute in Oklahoma City in 2000.
Dr. Malhotra returned to his hometown of St. Louis in 2000, when he joined Ophthalmology Associates in a partnership with Dr. Gregg Berdy.
Dr. Malhotra participates in and is the primary investigator for many FDA trials for medications used in the treatment of glaucoma, dry eye, conjunctivitis, allergy, and bacterial/viral infections.
About Scope
Scope offers innovative management products for Ocular Surface Disease and Age-Related Macular Degeneration, as well as a well-established food supplement range.
Scope operates in the UK, Ireland, and the USA with a product offering with a track record of successfully helping patients worldwide.
We have a reputation for:
- Providing premium & innovative products to enhance their patients' lives
- Strong customer service to both customers and patients
- Maintaining and building long term relationships with all Health Care Professionals that are key to our success
- Providing a full-scale service to an ethical and high professional standard
Last edited:
